ANIK Q2 2017 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$208M

Q2 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$33M+25.9% YoY

Gross Profit

$27M81.1% margin

Operating Income

$18M53.0% margin

Net Income

$11M34.0% margin

EPS (Diluted)

$0.76

QoQ Revenue Growth

+43.1%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$4M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$265M

Total Liabilities

$21M

Stockholders' Equity

$244M

Cash & Equivalents

$118M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$27M	+25.9%
Gross Profit	$27M	$21M	+32.3%
Operating Income	$18M	$13M	+31.6%
Net Income	$11M	$9M	+32.0%

Geographic Segments

UNITED STATES

$27M87%

Europe

$4M13%